A detailed history of Resolute Advisors LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Resolute Advisors LLC holds 16,777 shares of ATAI stock, worth $23,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,777
Previous 16,777 -0.0%
Holding current value
$23,655
Previous $22,000 13.64%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$1.17 - $2.7 $29,445 - $67,950
-25,167 Reduced 60.0%
16,777 $30,000
Q4 2022

Feb 09, 2023

BUY
$2.38 - $3.55 $99,826 - $148,901
41,944 New
41,944 $111,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $234M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Resolute Advisors LLC Portfolio

Follow Resolute Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Advisors LLC with notifications on news.